Maynard Ryan D - Insider Stock Trading - OpenInsider

CIK: 1363984 - Address: C/O Iovance Biotherapeutics, Inc., 825 Industrial Road, 4Th Floor, San Carlos, CA 94070

14 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	1	1	4	-1	-1	-8	-27	-32	-65	-22
S	%wins				100	75	75	100	100	100	92

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
11/14/24 17:00	11/12/24	IOVA	Iovance Biotherapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Maynard Ryan D	CA	D		M.d	373	7.45	0	50		8	D
11/14/24 17:00	11/12/24	IOVA	Iovance Biotherapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Maynard Ryan D	CA	D		S.d	-503	10.06	0	-50	-87	8	D
2/12/24 17:15	2/8/23	CARA	Cara Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CT	O	CFO	S	-3	0.5300	0	-5	-41	8	D
6/2/22 20:02	5/31/22	IOVA	Iovance Biotherapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Maynard Ryan D	CA	D		P	51	6.75	0	8	New	8	D
11/7/17 21:07	11/3/17	RIGL	Rigel Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CA	O	EVP,CFO	M.d	214	2.14	0	100		0	D
11/7/17 21:07	11/3/17	RIGL	Rigel Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CA	O	EVP,CFO	S.d	-390	3.90	0	-100	-100	0	D
9/14/12 19:57	9/12/12	RIGL	Rigel Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CA	O	EVP,CFO	M.ad	151	6.49	2	23		0	D	20	38	22	26	1	6	6	2	-1	-1	-11	-37	-30	-66
9/14/12 19:57	9/12/12	RIGL	Rigel Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CA	O	EVP,CFO	S.ad	-249	10.67	2	-23	-100	0	D	20	38	22	26	1	6	6	2	-1	-1	-11	-37	-30	-66
9/14/12 18:19	9/7/12	RIGL	Rigel Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CA	O	EVP,CFO	M.d	151	6.49	2	23		0	D	20	38	22	26	1	6	6	2	-1	-1	-11	-37	-30	-66
9/14/12 18:19	9/7/12	RIGL	Rigel Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CA	O	EVP,CFO	S.d	-249	10.67	2	-23	-100	0	D	20	38	22	26	1	6	6	2	-1	-1	-11	-37	-30	-66
9/11/12 18:07	9/7/12	RIGL	Rigel Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CA	O	EVP,CFO	M.dm	336	6.49	2	52		0	D	19	39	15	33	-9	7	6	3	-1	-4	-15	-22	-35	-69
9/11/12 18:07	9/7/12	RIGL	Rigel Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CA	O	EVP,CFO	S.dm	-545	10.54	2	-52	-100	0	D	19	39	15	33	-9	7	6	3	-1	-4	-15	-22	-35	-69
8/9/12 17:39	8/7/12	RIGL	Rigel Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CA	O	EVP,CFO	M.d	11	6.49	4	2		0	D	16	32	4	16	11	0	-10	-6	-1	1	7	-12	-33	-58
8/9/12 17:39	8/7/12	RIGL	Rigel Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Maynard Ryan D	CA	O	EVP,CFO	S.d	-18	10.61	4	-2	-100	0	D	16	32	4	16	11	0	-10	-6	-1	1	7	-12	-33	-58

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact